[Federal Register Volume 60, Number 70 (Wednesday, April 12, 1995)] [Notices] [Page 18618] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 95-8920] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Manufacturer of Controlled Substances; Notice of Application Pursuant to Sec. 1301.43(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on January 30, 1995, Mallinckrodt Chemical, Inc., Mallinckrodt & Second Streets, St. Louis, Missouri 63147, made application to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed below: ------------------------------------------------------------------------ Drug Schedule ------------------------------------------------------------------------ Tetrahydrocannabinols (7370)................................ I Methylphenidate (1724)...................................... II Cocaine (9041).............................................. II Codeine (9050).............................................. II Diprenorphine (9058)........................................ II Etorphine Hydrochloride (9059).............................. II Dihydrocodeine (9120)....................................... II Hydrocodone (9193).......................................... II Levorphanol (9220).......................................... II Meperidine (9230)........................................... II Methadone (9250)............................................ II Methadone-intermediate (9254)............................... II Dextropropoxyphene, bulk (non-dosage forms) (9273).......... II Morphine (9300)............................................. II Thebaine (9333)............................................. II Opium extracts (9610)....................................... II Opium fluid extract (9620).................................. II Opium tincture (9630)....................................... II Opium powdered (9639)....................................... II Opium granulated (9640)..................................... II Oxymorphone (9652).......................................... II Alfentanil (9737)........................................... II Sufentanil (9740)........................................... II Fentanyl (9801)............................................. II ------------------------------------------------------------------------ The firm plans to produce bulk finished products for distribution to its customers. Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the above application and may also file a written request for a hearing thereon in accordance with 21 CFR 1301.54 and in the form prescribed by 21 CFR 1316.47. Any such comments, objections, or requests for a hearing may be addressed to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, D.C. 20537, Attention: DEA Federal Register Representative (CCR), and must be filed on later than May 12, 1995. Dated: April 4, 1995. Gene R. Haislip, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 95-8920 Filed 4-11-95; 8:45 am] BILLING CODE 4410-09-M